Human immunodeficiency virus type 1 (HIV-1) assembly is an ordered series of steps that is characterized by the formation of intermediate assembly complexes of the viral precursor Gag or pr55
Gag . While the expression of pr55 Gag alone is sufficient to generate virus-like particles (9) , viral assembly steps following pr55
Gag synthesis are poorly defined. Each step of the assembly process appears to be regulated by distinct domains of pr55
Gag . Since the minimal Gag domain for selfassociation was recently shown to be the nucleocapsid (NC) (47) , oligomerization of pr55
Gag mediated by the NC domain is thought to be one of the first events of the assembly process. NC's role in assembly has also been shown to depend on its nonspecific RNA binding activity, mediated by basic amino acid residues (8, 11) .
The capsid (CA) (14, 30, 48) , matrix (MA) (21, 32) and p2 (31) 
domains of pr55
Gag all contribute to the highly ordered steps of Gag multimerization that likely lead to ultrastructural and morphological changes of intracellular assembly complexes. Although the MA domain is dispensable for multimerization, it is essential to target Gag to membranes via its amino-terminal myristylic acid, and it is also a critical determinant for particle formation (20, 37) . Genomic RNA is selected for packaging by the NC domain of pr55 Gag , and the p6 domain of pr55
Gag is involved in virus budding and release (9) . Following these steps, pr55
Gag is processed by the viral protease to generate MA, CA, NC, p6 proteins, and two spacer peptides, p2 and p1, leading to structural rearrangements and the formation of a mature virus (9) .
HIV-1 assembly also involves the activity of several cellular factors that, for the most part, interact with pr55
Gag to mediate their incorporation. An ATP-binding protein, HP68, was found to colocalize and interact with pr55
Gag and to participate in virion assembly and capsid formation (50) . Tsg101 is an endosomal sorting protein that influences morphogenesis and budding events via an interaction with pr55
Gag (17) . The proteins VAN, EF-1␣, and actin all interact with pr55
Gag and are present in purified virus preparations but have poorly defined roles in assembly and morphogenesis, gene expression, and earlier events of the HIV-1 life cycle (6, 10, 28, 38, 45) . These data underscore the importance of studying pr55
Gag -host interactions during the late assembly steps of the HIV-1 life cycle because these interactions can potentially be exploited as new targets for therapeutic intervention (19) .
We recently demonstrated that the double-stranded-RNAbinding protein Staufen is selectively packaged into HIV-1 virions and is associated with viral RNA in the cytoplasm and in the virus (34) . Staufen incorporation in HIV-1 depends on the integrity of the principal double-stranded-RNA-binding domain, dsRBD3 (34) , and it is likely mediated by its RNAbinding capacity (34) . These data strongly favored a role for Staufen in the selection of genomic RNA for encapsidation and also inferred that it functioned somehow in the intravirion HIV-1 ribonucleoprotein or reverse transcription complex. While Staufen is proving to be involved in RNA trafficking in mammalian cells, especially in neuronal cells (24) , details about its roles in HIV-1 replication remain obscure.
In this study, we provide new information on the virus-host interaction involving Staufen from in vitro experiments as well as in live cells. We show that Staufen cofractionates with pr55
Gag within detergent-resistant cytosolic complexes and is a component of an intracellular HIV-1 ribonucleoprotein complex. Furthermore, we demonstrate that Staufen interacts specifically with the NC domain of pr55
Gag in a direct and RNAindependent manner, as shown in vitro as well as in live-cell assays. We also show that the HIV-1 genomic RNA and not the 1.8-or 4-kb spliced RNA species selectively coimmunoprecipitates with Staufen. Finally, RNA interference experiments demonstrate that specific knockdown of Staufen gene expression results in a significant reduction in viral infectivity. The results presented here suggest that Staufen influences HIV-1 replication at steps that include viral assembly and that this is achieved via specific interactions with HIV-1 pr55
Gag and genomic RNA.
MATERIALS AND METHODS
Cell culture and transfection. 293T cells were grown at 37°C in Dulbecco's modified Eagle's medium containing 8% fetal bovine serum and antibiotics (Gibco-BRL, Invitrogen). All transfections were performed with the calcium phosphate-mediated coprecipitation method as reported (34) except that a lipofection technique was used for the silent interfering RNA (siRNA) experiments described below.
Construction of chimeric proviruses. The hemagglutinin (HA)-tagged Staufen cDNA was PCR amplified from pcDNA3-RSV-Staufen-HA (44) with Pfu polymerase (Stratagene) and sense (5Ј-GATGCTCGAGATGAAACTTGGAAAA AAACC-3Ј) and antisense (5Ј-CACATCTAGATCATTTATTCAGCGGCCGC ACTGAGCAGCGT-3Ј) oligonucleotides. The resulting PCR products were digested with XhoI and XbaI and cloned in pNL4-3/PKR (4) to replace the XhoI and XbaI pkr fragment in the nef open reading frame. The same approach was used to introduce two Staufen mutants in the nef open reading frame: a fulllength Staufen protein with a point mutation in dsRBD3 (Staufen F135A ) and a C-terminally truncated mutant (dsRBD2-4) lacking the tubulin binding domain (TBD) and dsRBD5. HxBRU provirus (46) was used in the siRNA experiments described below.
Construction of Gag expressers. DNA fragments encoding full-length or different parts of HxB2 Gag polyprotein were PCR amplified with the Pfu Turbo DNA polymerase (Stratagene) and the Rev-independent Gag expresser plasmid pCMV55M1-10 (40) as the template. The primer pairs used in the PCRs are summarized in Table 1 . PCR products were digested with KpnI and BamHI and inserted in the KpnI and BamHI cloning sites of pRluc-N1(h) (Packard BioScience/Perkin-Elmer Life Sciences) in frame with the Renilla reniformis luciferase coding sequence (1). To construct pCMV-Staufen/YFP, pcDNA3-RSVStaufen-HA (44) was digested with NotI, treated with the Klenow fragment of DNA polymerase to blunt the extremities, and digested with HindIII. The resulting fragment was then inserted in the HindIII and SmaI sites of pCMV-GFPTopaz (1) in frame with the yellow fluorescent protein (YFP) coding sequence.
Cell fractionation on sucrose gradients. 293T cells were homogenized for 1 min in 12.5% sucrose-10 mM HEPES (pH 7.3)-1 mM EDTA and then centrifuged at 1,000 ϫ g for 5 min. The supernatant was layered onto a continuous 20 to 60% (wt/vol) sucrose gradient (in 10 mM HEPES [pH 7.3], 1 mM MgCl 2 ) as reported previously (29) . In other experiments, to increase stringency, cells were homogenized in a lysis buffer containing detergent (100 mM NaCl, 10 mM Tris, 1 mM EDTA, 0.5% NP-40, pH 7.3) and layered onto a 10-ml continuous 10 to 60% (wt/vol) sucrose gradient. Both gradients were centrifuged at 31,000 ϫ g for 2.5 h in an SW41 rotor (Beckman-Coulter). Fractions were collected from the top and analyzed by Western blotting for Staufen (with mouse monoclonal anti-HA or anti-Staufen antibodies), CA, MA (from Spearman, NIH AIDS Reference and Reagent Program), and ribosomal L7 (Novus Biologicals).
Immunoprecipitation and RT-PCR. 293T cells were either transfected with Staufen-expressing chimeric proviruses or cotransfected with cDNAs coding for Gag/Rluc and Staufen-HA fusion proteins. Forty hours posttransfection, cells were harvested, washed three times in phosphate-buffered saline (PBS), and lysed (100 mM NaCl, 10 mM Tris, 1 mM EDTA, 0.5% NP-40, and protease inhibitor cocktail [Roche] ). Staufen and Gag expression was monitored by Western blot analysis with mouse monoclonal anti-HA and anti-CA antibodies, respectively. For immunoprecipitation analysis, 3 to 5 mg of cell lysates was precleared with normal rabbit serum and 25 l of a 50:50 slurry of protein A-Sepharose (Amersham Biosciences), incubated with rabbit polyclonal anti-CA antiserum (American BioTechnologies; dilution 1:200) for 90 min at 4°C, and with 25 l of a 50:50 slurry of protein A-Sepharose for 1 h at 4°C.
To immunoprecipitate HA-tagged proteins, lysates were incubated with rat monoclonal anti-HA antibody covalently coupled with agarose beads (Roche Applied Bioscience) for 4 h at 4°C. In some cases, the stringency of the immunoprecipitation was increased by adjusting the concentrations of NP-40 and sodium dodecyl sulfate to 1% and 0.1%, respectively. The resulting immunoprecipitation pellets were washed four times with lysis buffer and once with PBS. Immunoprecipitates were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with mouse monoclonal anti-HA and anti-CA antibodies to detect Staufen and Gag in Western blot analyses. The immunoprecipitation of endogenous Staufen was performed essentially as described above for anti-CA except that a mouse monoclonal antiserum was used (34) . A rabbit antiserum was used to identify Staufen in Western analyses.
To identify Staufen-associated RNAs, Staufen-HA was first immunoprecipitated with a monoclonal anti-HA antibody as previously described (34) . The immunoprecipitation pellets were incubated with 20 g of RNase-free DNase I (Invitrogen) for 1 h at 37°C and then with 50 g of proteinase K for 30 min at 42°C. Coprecipitated RNAs were extracted as described before (34) , dissolved in diethylpyrocarbonate-treated water, and reverse transcribed with random primers and avian myeloblastosis virus reverse transcriptase with the First Strand cDNA synthesis kit (Roche Applied Bioscience). The resulting cDNAs were PCR amplified with Taq polymerase (Roche Applied Bioscience) and either of three primer pairs that discriminate between the three HIV RNA size classes. All three sets include the same sense primer (5Ј-CTGAGCCTGGGAGCTCTCTG GC-3Ј ) present in the TAR region of all HIV-1 RNA species (34) .
Primer pair 1 specifically amplify a 430-bp fragment from the genomic HIV-1 (39) . Labeled PCR products were resolved on 6% denaturing polyacrylamide gels and detected by autoradiography.
BRET analysis. For bioluminescence resonance energy transfer (BRET) analysis, 293T cells (2 ϫ 10 6 ) were cotransfected with cDNAs coding for Staufen/ YFP and different Gag/Rluc fusion proteins. Forty hours posttransfection, the cells were washed in PBS, collected in 1 ml of PBS containing 5 mM EDTA, and then diluted to 10 6 cells/ml. Coelenterazine (h; Molecular Probes) was added at a final concentration of 5 M. Luminescence and fluorescence were quantitated with a Fusion ␣-FP apparatus (Perkin-Elmer-Canberra Packard BioScience). Three measures were obtained: first, light emitted at 475 to 480 nm by Renilla luciferase; second, emission fluorescence at 525 to 530 nm without excitation due to energy transfer from Renilla luciferase to YFP; third, emission fluorescence at 525 to 530 nm after excitation at 485 nm to measure total expression of YFP fusion proteins. The BRET ratio was defined as [(emission at 510 to 590 nm) Ϫ (emission at 440 to 500 nm) ϫ Cf]/(emission at 440 to 500 nm), where Cf corresponds to (emission at 510 to 590 nm)/(emission at 440 to 500 nm) for Renilla luciferase-fused Gag mutants expressed alone in the same experiments, as previously described (1) .
To ensure that the BRET ratios reflected a real interaction between fusion proteins, dose-response assays were performed for each protein tested. 293T cells were cotransfected with constant amounts of different Gag/Rluc fusion proteins and increasing concentrations of either Staufen/YFP or YFP alone. At each concentration, the BRET ratios were determined as described above and plotted as a function of the ratio of total YFP activity after excitation to total Renilla luciferase activity. These curves allowed us to compare BRET ratios obtained with Staufen/YFP (due to specific interaction with Gag/Rluc) and YFP alone (control) at the same expression levels. In these conditions, whereas BRET ratios increased linearly with YFP concentrations, they increased more rapidly and were eventually saturated as the expression level of Staufen/YFP increased, reflecting a specific interaction between Staufen and Gag.
siRNA knockdown: transfections, Western blots, and RT-PCR analysis. Four double-stranded 21-bp siRNAs to a selected region of Staufen cDNA were chosen and tested for Staufen knockdown efficiency in preliminary experiments. The duplex siRNA 3084 (5Ј-AAATAGCACAGTTTGGAAACT-3Ј) was determined to produce the most significant knockdown of Staufen gene expression and was chosen for the experiments presented in this article (purchased from Qiagen-Xeragon, Germantown, Md.). A control nonsilencing siRNA (catalog no. 1022076; 5Ј-AATTCTCCGAACGTGTCACGT-3Ј) was purchased from Qiagen-Xeragon and included in either mock or HxBRU (vpr ϩ vif ϩ nef Ϫ vpu Ϫ )-transfected cells. 293T cells were trypsinized and plated in six-well plates at 2 ϫ 10 5 cells per well for 12 to 16 h before transfection. Transfections were performed with the Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, Calif.) with siRNA at a final concentration of 10 nM. Cells were transfected with either nonsilencing siRNA (mock or HxBRU) or Staufen siRNA 3084. At 24 h, the cells were mock-transfected (KSII with nonsilencing siRNA) or transfected with HxBRU plus nonsilencing RNA or plus Staufen siRNA 3084; 24 h later, the cells were washed with ice-cold PBS and lysed in NP-40 buffer (100 mM NaCl, 10 mM Tris, 1 mM EDTA, 0.5% NP-40). Virus was pelleted by ultracentrifugation of supernatants.
Cytosolic extracts quantitated for protein by the micro-Bradford assay and for Staufen and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were assessed by Western blot analysis with a mouse monoclonal anti-Staufen antibody (9E9) as described above and a GAPDH antibody (Research Diagnostics, Inc.) Actin was also identified with an antiactin antibody (not shown). The other half of the cellular extract was treated with urea buffer and phenol-chloroformisoamyl alcohol to extract cytosolic RNA (33) . RNA was precipitated with ethanol and glycogen carrier (Roche). The RNA pellets were resuspended in diethylpyrocarbonate-treated water and quantitated by optical density measurement; 1 g of RNA from each sample was used in RT-PCR analysis with the Superscript One-Step RT-PCR kit with Platinum Taq (Invitrogen). Either Staufen mRNA to produce a 337-bp PCR product (sense, 5Ј-aatctagaTTTAC CAGGGCAGCTCCGAA-3Ј; antisense, 5Ј-aatctagaCAACTCAGACAGCAAC TTTAAGATGT-3Ј; lowercase indicates restriction sites) or GAPDH RNA exactly as described in reference 23 was specifically amplified as described previously (34) .
HIV-1 infectivity assay. 293T cells were treated with a nonsilencing siRNA (mock or HxBRU alone) or treated with Staufen siRNA 3084 as described above. Virions produced from 293T cells were collected, filtered, and pelleted by ultracentrifugation; 8 ϫ 10 5 CEM-green fluorescent protein (GFP) cells (18) were infected with equivalent amounts (25 ng) of virus as determined by p24 enzyme-linked immunosorbent assay (ELISA) (3, 5) in the presence of 10 g of Polybrene (Sigma-Aldrich) per ml and in a final volume of 200 l of culture medium. At 3 h postinfection, CEM-GFP cells were resuspended in 10 ml of fresh medium (RPMI with 10% fetal bovine serum and 500 g of G418 per ml) and incubated for 48 h. The cells were then pelleted, washed twice with PBS, and fixed in 1% formaldehyde in PBS. Then 10 6 viable cells were transferred to a 96-well plate. Fluorescence was measured with a Fusion-Alpha reader apparatus (Perkin-Elmer Life Sciences) with an excitation wavelength of 485 nm and an emission wavelength of 520 nm. Data are expressed as relative infectivity where wild-type HIV-1 infectivity (HxBRU treated with a nonsilencing siRNA) was arbitrarily set to a value of 1.
RESULTS

Expression of Staufen from HIV-1 chimeric proviruses.
To characterize a putative interaction between Staufen and HIV-1 proteins or RNA, we constructed HIV-1 chimeric proviruses in which Staufen cDNA was inserted into the nef open reading frame (Fig. 1A) . In this context, Staufen should be expressed early during HIV-1 expression, since Nef is among the first viral proteins to be expressed. We also prepared two additional chimeric proviruses containing either the full-length Staufen protein with a point mutation in dsRBD3 that abolishes its RNA-binding capacity (Staufen F135A ) or a C-terminally truncated mutant (dsRBD2-4) lacking the tubulin binding domain and the dsRBD5. To verify Staufen expression in this proviral context, expression levels were analyzed by Western blotting of extracts of transfected 293T cells. As shown in Fig. 1B , Staufen proteins were all expressed at comparable levels. In addition, Staufen expression in the context of the provirus did not affect Gag expression levels or Gag processing, since the same levels of pr55
Gag , CA, and CAp25 were observed (Fig. 1B) .
Staufen and HIV-1 pr55
Gag cofractionate on sucrose gradients. We first studied the subcellular distributions of Staufen and HIV-1 Gag during HIV-1 replication. These studies showed that Staufen and pr55
Gag partially colocalized in the cytoplasm of HIV-1/Staufen-expressing cells (L. ChantalChaix, L. DesGroseillers, and A. J. Mouland, data not shown). We therefore performed sucrose gradient sedimentation assays in order to determine the relationships between cytosolic Staufen and HIV-1 pr55
Gag or CA. This technique allows the separation of cellular compartments or organelles according to their buoyant density. Cytoplasmic cell extracts were prepared from pNL4-3-and pNL4-3/Staufen-HA-expressing cells and separated on sucrose gradients (20 to 60%, wt/vol; Fig. 2A and B). Each fraction was analyzed by Western blotting for the presence of Staufen and HIV-1 proteins. In cells that expressed pNL4-3 only, endogenous Staufen was found in fractions 10 to 13, with a peak in fraction 13. Ribosomal protein L7, a marker of whole ribosomes, was also found in these Staufen fractions ( Fig. 2A) , as shown previously (29) . When anti-CA was used to identify Gag proteins, unprocessed pr55
Gag , like Staufen, was principally found in fractions 11 to 14 with a peak in fraction 13 (indicated in the shaded box 2B ). In contrast, the processed forms of pr55 Gag , CA p24 and p25, sedimented mainly in fractions 6 to 12, likely corresponding to budding viruses. Approximately 50% of the total CA was detected in the low-density fraction 15, likely representing lysed viruses. Identical results were obtained for the distribution of Staufen-HA in cells expressing pNL4-3/Staufen-HA (Fig. 2B ) such that Staufen cofractionated with pr55
Gag and not with the processed forms of pr55
Gag . This set of experiments demonstrated that while the distributions of Staufen and pr55
Gag were not identical, both proteins cosedimented in sucrose gradients and peaked in the same fraction. It also shows that the expression of Staufen in the context of pNL4-3/Staufen did not affect the cytoplasmic distribution of HIV-1 proteins, and moreover, HIV-1 gene expression did not have any apparent effects on that of Staufen.
To further characterize these complexes, we repeated these sucrose gradient analyses in the presence of nonionic detergent ( Fig. 2C) Gag . These proteins sedimented in fractions 7 to 13 (34.5 to 24% sucrose) after detergent treatment (Fig. 2C) or mainly in fractions 10 to 13 (34.5 to 25% sucrose) without detergent ( Fig. 2A or 2B) . In contrast, the processed forms of Gag such as CA p25 and p24 and MA (not shown) were no longer present in high-density fractions (6 to 12 in Fig. 2A and B) but were found at the top of the gradient (mainly in fractions 14 and 15) following detergent treatment, likely corresponding to detergent-solubilized viral particles. Therefore, Staufen and pr55
Gag are found in detergent-resistant complexes, consistent with previous Gag data (26, 27) . When cell extracts were treated with trypsin before gradient analysis, neither Staufen nor pr55
Gag was detectable in sucrose gradients, indicating that both proteins are sensitive to trypsin digestion and are mainly in a cytosolic compartment (ChatelChaix et al., data not shown). In contrast, CA p25/p24 levels and distribution were not affected because they are most likely protected from trypsin by their association with membranes. Our results now show that Staufen cofractionates with pr55 Gag and is likely part of the same HIV-1 detergent-resistant complex, a complex that was previously shown to mainly contain pr55
Gag and to correspond to cytoplasmic virion assembly intermediates (26, 27) .
Staufen interacts with HIV-1 pr55
Gag in an RNA-independent manner. In preliminary studies, yeast two-hybrid analyses revealed that full-length Staufen and pr55
Gag interacted (34) to a level similar to that found for pr55
Gag /pr55 Gag (2). Our immunofluorescence results also suggested that at least a proportion of Staufen and pr55
Gag are in close proximity and could be components of the same HIV-1 assembly complex (data not shown). To address this possibility, we first determined whether endogenous Staufen interacted with pr55 Gag during proviral expression. To determine this, cells were mock transfected or transfected with pNL4-3 alone. Extracts from these cells were immunoprecipitated with a monoclonal anti-CA antibody. A cell extract was analyzed for endogenous Staufen prior to immunoprecipitation with a rabbit polyclonal antibody used previously (34) (Fig. 3A, top left panel) . This antibody reacts with two isoforms of Staufen, 55 and 63 kDa (34) . pr55
Gag was then immunoprecipitated from equal quantities of extracts, and the immunoprecipitates were analyzed for the presence of endogenous Staufen protein (Fig. 3A , top right panel) and immunoprecipitated Gag products (Fig. 3A,  lower panel) . Staufen was found to be present in the HIV-1 Gag immunoprecipitates during HIV-1 expression but not in the immunoprecipitate from mock-transfected cell lysates. There was a specific immunoprecipitation with the 55-kDa Staufen isoform (Fig. 3A, top right panel) . A 63-to 65-kDa protein signal was obtained in both conditions and is not related to the 63-kDa Staufen isoform. These results suggest that endogenous Staufen is physically recruited to pr55
Gag -containing complexes during proviral gene expression.
In order to map the determinants in the Staufen protein that are important for this interaction, 293T cells were trans- (Fig. 3B ). An approximately equal amount of Gag (pr55 Gag , pr41 Gag , or CA p24 and p25) was immunoprecipitated in all conditions. These results demonstrate that Staufen's interaction with pr55
Gag in HIV-1-expressing cells requires contributions from both an intact dsRBD3 and Cterminal domain.
In the reverse experiment, cells were transfected with pNL4-3 or the pNL4-3/Staufen proviruses, and Staufen-HA was immunoprecipitated with anti-HA. Immunoprecipitated proteins were then analyzed by Western blot analysis with monoclonal anti-CA. Anti-HA was included to identify Staufen-HA proteins at the same time. This analysis shows that pr55
Gag coimmunoprecipitated with wild-type Staufen-HA but not with either of the Staufen mutants (Fig. 3C) . We were not able to detect processed forms of pr55
Gag , CA, and NC in the immunoprecipitates (data not shown), consistent with our gradient analysis, in which we showed that these do not cofractionate with Staufen ( Fig. 2A and B) . These data strongly suggest that Staufen preferentially interacts with the Gag precursor pr55
Gag . Since a single point mutation in Staufen's dsRBD3 abolishes both its RNA-binding activity (29) and the Staufen/pr55 Gag interaction (Fig. 3B) , we investigated whether RNA contributes to this interaction, as it does for the pr55
Gag /EF-1␣, pr55
Gag /pr55 Gag , and pr55 Gag /Gag-Pol (or pr160 Gag/Pol ) interactions (8, 10, 11, 22) . Cell lysates were mock digested or digested with RNases A and T 1 prior to immunoprecipitation with anti-CA antiserum. As shown in Fig. 3D , Staufen remained associated with Gag-containing complexes in the presence of RNase, demonstrating that this interaction is maintained even if the cellular RNA is removed. However, we cannot exclude the possibility that bridging RNA may be protected from RNase digestion by the Staufen/pr55
Gag complex with this assay, and these results, while reproducible, should be interpreted with care.
Staufen/pr55 Gag interaction requires the HIV-1 NC domain. Coimmunoprecipitation assays were also used to map the pr55 Gag domain that interacts with Staufen. Full-length pr55
Gag as well as four deletion mutants containing different Gag subdomains (MA-CA, CA, CA-p1, and CA-p6) were fused in-frame with R. reniformis luciferase (Fig. 4A) . The CA subdomain was included in each mutant in order to allow immunoprecipitation by our anti-CA antibody. 293T cells were cotransfected with the Gag/Rluc and Staufen-HA expressors. In the cell lysates, the Gag/Rluc deletion mutants and Staufen-HA were all expressed at comparable levels except for pr55
Gag /Rluc, which was consistently expressed at low levels (Fig. 4B ). Following immunoprecipitation with anti-CA antibodies, coprecipitated proteins were analyzed by Western blotting with anti-HA to detect Staufen-HA (Fig. 4C) . Although each Gag mutant was immunoprecipitated at comparable levels (Fig. 4C , bottom panel), Staufen-HA was only detected in the immunoprecipitates when the NC subdomain was expressed (lanes 1, 4, and 5). These results show that Staufen interacts with pr55 Gag with a major contribution from the NC domain. Negligible amounts of Staufen-HA coprecipitated with CA/Rluc and MA-CA/Rluc. Moreover, these results suggest that the interaction does not require the expression of additional viral components.
Staufen and HIV-1 NC domain of pr55
Gag interact directly in live cells. To determine whether the characterized Staufen/ pr55
Gag interaction above was not an artifact that resulted from the preparation of detergent-solubilized cellular extracts, we performed protein interaction assays in live cells by BRET analysis (1) . For this method, a BRET is achieved when two proteins interact directly with a physical separation of approximately Յ50 Å . Energy from the donor luciferase molecule is transferred to the red-shifted GFP (YFP) molecule acceptor, which then produces a fluorescent light emission to produce a positive BRET signal, calculated as described in Materials and Methods. Staufen was fused to YFP (acceptor), and all of the Gag mutants were fused to Renilla luciferase (donor) as shown in Fig. 5A . 293T cells were cotransfected with Staufen-YFP and each of the Gag/Rluc expressers, and BRET ratios were determined in live cells at 40 h posttransfection. Because fulllength pr55
Gag /Rluc was poorly expressed (Fig. 4B) , it was not included in this set of experiments.
As shown in Fig. 5A , positive BRET ratios were always observed when Staufen-YFP was coexpressed with Gag mutants containing the NC domain (CA-p1/Rluc, CA-p6/Rluc, p2-p1/Rluc, and NC/Rluc). In contrast, negligible BRET ratios were obtained when the Gag fragments lacked the NC domain (MA-CA/Rluc, CA/Rluc, MA/Rluc, and p6/Rluc). Positive BRET ratios were consistently two-to threefold higher when NC was expressed in the form of a precursor (CA-p1 or CA-p6/Rluc) than when it was expressed as a mature protein (NC/Rluc). Dose-response assays with cells transfected with Staufen/YFP or YFP alone provided further evidence that this association in live cells was specific (Fig. 5B and Materials and Methods). These data confirm the results obtained in the coimmunoprecipitation analyses and further show that Staufen and pr55
Gag interact directly in live cells. We mapped the pr55
Gag -interacting domain to the NC domain, and the data 
FIG. 5. Staufen directly binds the HIV-1 NC domain of pr55
Gag in living cells. (A) 293T cells were cotransfected with Staufen/YFP and different Renilla luciferase-fused truncated Gag expressers. BRET ratios were defined as described in Materials and Methods. n is the replicate number, and the error bars represent the standard error of the mean calculated from at least three experiments for each interaction set. (B) 293T cells were cotransfected with constant amounts of pCMV-CA-p1/Rluc and various amounts of either Staufen/YFP or YFP expressers. The graph presented here is a representative example of the saturation studies performed to provide evidence for a specific interaction between the proteins. BRET ratios were plotted as a function of the excited YFP activity to total Renilla luciferase activity ratio, allowing comparison of BRET ratios between Staufen-YFP and YFP when expressed at the same levels. HIV-1 genomic RNA is found in the Staufen immune complex. We previously documented a direct correlation between the level of expression of Staufen and the abundance of genomic RNA encapsidated into virus particles (34) . This suggested that Staufen was implicated in the selection of genomic RNA for encapsidation. While the NC domain of pr55
Gag is the principal mediator of this process (49) , which depends on an interaction between pr55
Gag and genomic RNA (13) , the relationship between Staufen-and pr55
Gag -mediated genomic RNA encapsidation was not clear. Therefore, to further characterize the Staufen-pr55
Gag complex and the relationship between Staufen and HIV-1 RNA, we attempted to identify the Staufen-associated HIV-1 RNA species in coimmunoprecipitation assays with our Staufen proviral constructs. 293T cells were transfected with pNL4-3/Staufen-HA and mutant proviruses, and cell extracts were immunoprecipitated with anti-HA. The identification of the coimmunoprecipitated HIV-1 RNA species was determined by RT-PCR with three primer pairs that recognized either the genomic RNA or the 4-or 1.8-kb spliced RNAs, as previously described (39) and as illustrated in Fig. 6A .
With primer pair 1 for genomic RNA, we detected a specific DNA product of the expected size in the immunoprecipitates isolated from HIV-1/Staufen-HA lysates (Fig. 6B, lane 3) . The amplification was specific because there was no signal when the avian myeloblastosis virus reverse transcriptase was omitted (Fig. 6B, lane 7) . In contrast, RT-PCR from HIV-1 alone (Fig.  6B, lane 2) or from the pNL4-3/Staufen F135A -HA or pNL4-3/ dsRBD2-4-HA immunoprecipitates did not lead to a detectable PCR product with the primer pair for genomic RNA (Fig.  6B, lanes 4 and 5) . With the same immunoprecipitated RNA extracts, RT-PCR was repeated with primer pairs specific for spliced HIV-1 RNAs. In both cases, there was no evidence of a PCR product after 35 cycles (Fig. 6C and 6D ). To further rule out the presence of spliced HIV-1 RNAs following the RT reaction, PCR was performed and the last two or five PCR cycles were performed in the presence of [ 32 P]dCTP. PCR products were resolved on 6% polyacrylamide gels. As shown in Fig. 6E and F, we did not detect an association with the 4-and 1.8-kb RNA species even in these conditions.
The expected pattern of spliced RNAs was obtained with cell extracts from pNL4-3-expressing cells with this strategy (Fig. 6E and F) (39) . These results demonstrate that there is selectivity for genomic RNA by Staufen in HIV-1-producing cells, supporting a role for Staufen in the selection of genomic RNA for encapsidation. This immunoprecipitation/RT-PCR analysis was also performed for endogenous Staufen during the expression of HIV-1, and the results also demonstrate that HIV-1 genomic RNA selectively coimmunoprecipitates with Staufen (data not shown). Furthermore, similar analyses were performed with the related double-stranded-RNA-binding protein TRBP. Whereas Staufen exhibited selectivity for the 9-kb RNA as described above, TRBP was found to coimmunoprecipitate with all HIV-1 RNA species (data not shown).
Staufen knockdown by RNA interference generates HIV-1 with compromised infectivity. Staufen expression was targeted by 21-bp siRNA duplexes as described in Materials and Methods. Cells were either mock transfected (with a nonsilencing control RNA duplex) or transfected with HxBRU (plus a nonsilencing control RNA duplex) or with HxBRU/Staufen (plus Staufen siRNA 3084) following the procedure described in Materials and Methods. Staufen siRNA 3084 knocked down Staufen protein expression by 80% (Fig. 7A) and Staufen mRNA levels by almost 60%, as shown in RT-PCR analyses (Fig. 7B) . Staufen siRNA 3084 did not affect either GAPDH protein and RNA levels ( Fig. 7A and B) or those of actin (data not shown), However, when HIV-1 infectivity was assessed with equal quantities of virus, as determined in a p24 ELISA (3, 5) , Staufen siRNA 3084 resulted in a twofold drop in viral infectivity (Fig. 7C) . In our previous work, Staufen overexpression also caused a significant decrease in viral infectivity (34) . These data demonstrate that an optimal amount of Staufen expression is required to produce fully infectious viral particles.
DISCUSSION
In this report, we show that the double-stranded-RNA-binding protein Staufen interacts with the NC domain of HIV-1 pr55
Gag during HIV-1 gene expression. This interaction was demonstrated in in vitro assays with both proviral and expression constructs and in live cells by BRET analysis, indicating that it is direct and does not require other viral components. Cellular Staufen/pr55
Gag complexes contain HIV-1 genomic RNA but not the spliced HIV-1 RNA species. They are resistant to membrane solubilization by detergent but are sensitive to trypsin proteolysis, two characteristics of cytoplasmic assembly detergent-resistant complexes (26, 27) . Taken together, these results suggest that Staufen plays a role during virus assembly and genomic RNA encapsidation. Consistently, our earlier work showed that Staufen overexpression resulted in decreased virus infectivity but at the same time resulted in enhanced genomic RNA packaging in virions (34) . The siRNA results shown in Fig. 7 further support a role for Staufen in virus assembly or at another level that impacts significantly on the infectious potential of virions. More recent work supports the notion that Staufen acts during assembly in that Staufen appears to affect virion morphogenesis (Mouland et al., unpublished data). It will be interesting to determine at what stage Staufen is acting in the assembly process, since other cellular proteins such as HP68 have been shown to be associated with several Gag assembly intermediates (50) .
Confocal imaging analysis of cells transfected with pNL4-3/ Staufen-HA provirus did not reveal any apparent changes in Staufen's cellular distribution compared to cells expressing Staufen alone (not shown). This is in contrast to the dramatic nuclear relocalization of Staufen when influenza virus NS1 protein is expressed (15) . Partial colocalization was found between HIV-1 Gag and Staufen, suggesting that a proportion of Staufen is associated with pr55
Gag at any time (data not shown). This interaction was substantiated by several assays, including yeast two-hybrid (34) , in vitro coimmunoprecipitation, and BRET analyses in live cells (Fig. 3 to 5) . The interaction appeared to be direct and was consistently found to be of the same order of magnitude as that found for Gag-Gag in these assays, indicating that this may reflect a transient association that is only required for specific steps in the viral replication cycle and/or to allow a fine-tuned regulation of assembly steps (Fig. 8) . Indeed, dynamic and transient formation and modification of ribonucleoprotein complexes is a major hallmark of RNA transport and localization (41) , and this also appears to be the case in the formation of an HIV-1 assembly complex (43, 50) .
Immunoelectron microscopy experiments revealed cytoplasmic assembly intermediates representing small Gag oligomers of about 10 molecules (36), likely corresponding to the previously described cytoplasmic detergent-resistant complexes (26, 27) and the complexes identified immediately following pr55 Gag synthesis (43) . Our results favor the idea that Staufen is recruited early by pr55 Gag in this cytoplasmic assembly detergent-resistant complex to participate in the first events of NC-mediated Gag multimerization. Consistently, the Staufen complexes identified in our fractionation studies had all the characteristics of cytoplasmic detergent-resistant complexes (Fig. 2) . Furthermore, the Staufen/pr55
Gag interaction does not require translocation to the membrane, since the interaction of Staufen with Gag occurred when the MA domain was absent (Fig. 4 and 5) . Since Staufen likely functions in mRNA trafficking in the cytoplasm (24) , it could participate in the translocation of the pr55
Gag assembly complexes and/or play a role in the recruitment of genomic RNA to sites of viral assembly.
The results presented in this article point to a role of Staufen in the posttranscriptional steps of the HIV-1 life cycle (Fig. 8) .
Staufen is likely to be recruited early during viral assembly by newly synthesized pr55
Gag via the NC domain (Fig. 8, step 1 ). Staufen's association with ribosomes (29) and the cosedimentation with ribosomes in sucrose gradients (Fig. 2) indicate that a Staufen-pr55
Gag -ribosome complex could represent an early assembly complex intermediate in the HIV-1 replication cycle. Cellular mRNAs and/or HIV-1 genomic RNA may then compete with ribosomes to release Staufen-Gag complexes (Fig. 8,  step 1 ). Consistently, a molecular competition is proposed to exist between ribosomal protein L18 and double-stranded RNA for the double-stranded-RNA-binding protein PKR (25) , and another that was proposed to exist between ribosomes and genomic RNA MLV for Moloney murine leukemia virus Gag that may result in the encapsidation of ribosomes instead of genomic RNA MLV (35) . Staufen could also contribute to the oligomerization of pr55
Gag by recruiting RNA, a component that was shown to be a necessary cofactor for this (8, 11) , or likewise promote the association of genomic RNA with pr55
Gag (Fig. 8, step 2) . Because Staufen is a cytoskeleton-associated protein and is involved in the transport of ribonucleoprotein complexes (24) , Staufen may mediate the transport of this assembly complex intermediate toward the plasma membrane, where a ternary assembly complex of Staufen, pr55
Gag , and genomic RNA is maintained to lead to genomic RNA encapsidation (Fig. 8,  step 3 ). While RNA does not appear to be an important cofactor for the Staufen/pr55
Gag association (Fig. 3D) , genomic RNA is necessary for Staufen incorporation because NC and packaging signal proviral mutants generate virus particles that are devoid of Staufen (34) . Because a single point mutation in the Staufen dsRBD3 abolishes both the genomic RNA and pr55
Gag association, a dual role for this domain is suggested, as demonstrated for several other related double-stranded-RNAbinding proteins such as PKR and TAR RNA-binding protein (12) . Knocking down Staufen expression by siRNA will likely disrupt early or subsequent steps of assembly through Staufen's interactions with pr55
Gag and RNA and contribute to the generation of poorly infectious virus particles (Fig. 7) . The contributions of each type of interaction of Staufen during the assembly process will require further analysis.
Sucrose gradient, coimmunoprecipitation, and BRET analyses strongly support a preferential association of Staufen with pr55
Gag and not with mature Gag proteins ( Fig. 2 to 5 ). This dictates that during Gag maturation by the viral protease, Staufen may be progressively excluded from Gag assembly complexes by modulation of its affinity for Gag (Fig. 8, step 4) . Structural changes in Gag during maturation were previously proposed to explain the partial exclusion of cyclophilin A from HIV-1 (7, 42) .
Staufen expression levels appear to be important for HIV-1 replication. For example, Staufen overexpression not only enhances the Staufen copy number within virus particles, but also correspondingly enhances the number of HIV-1 genomic RNA copies packaged into the virion (34) . It also results in morphological changes in virus particles (Mouland et al., unpublished data) , and this could be due to Staufen that is overrepresented in the Staufen-pr55
Gag -genomic RNA ternary complex during assembly. Staufen knockdown (Fig. 7) could also disrupt the composition of this ternary complex at this step of the assembly process. While proof that Staufen and HIV-1 genomic RNA interact directly has been difficult to show experimentally, it is tempting to speculate that genomic RNA dimerization during HIV-1 assembly may play a role in this switch of Staufen to associate with genomic RNA, especially since Drosophila Staufen's association with bicoid mRNA requires RNA dimerization (16). Staufen's selective association with a complex in which HIV-1 genomic RNA is found (Fig. 6) , especially compared to the absence of specificity exhibited by TRBP, is indicative of a role of Staufen in the fate of this RNA species during HIV-1 expression.
If Staufen participates in the selection of genomic RNA by NC for encapsidation in the context of this Gaggenomic RNA complex, for instance, we can anticipate that the fine-tuned regulation of the amounts of Staufen associated with fully assembled viral particles could represent a mechanism by which the appropriate number of genomic RNA molecules is packaged into HIV-1 to generate fully infectious viral particles. The experiments presented here and previously (34) support this model while current investigations are under way to study the other putative roles of Staufen during HIV-1 replication.
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